advanced breast cancer

Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Yahoo/Market Exclusive
Eli Lilly
Zosano
Verzenio
advanced breast cancer
M207
migraine
Flag link:
In a showdown with AstraZeneca, Pfizer posts solid — and very familiar — PhIII breast cancer data for talazoparib
In a showdown with AstraZeneca, Pfizer posts solid — and very familiar — PhIII breast cancer data for talazoparib
Endpoints
Pfizer
AstraZeneca
talazoparib
advanced breast cancer
Lynparza
PARP inhibitors
Flag link:
AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting
AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting
Yahoo/Zacks.com
AstraZeneca
Faslodex
FDA
advanced breast cancer
Flag link:
3 Most Promising Cancer Drugs in Late-Stage Development
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer
Flag link:
Novartis, IBM Watson collab to optimize care for patients with advanced breast cancer
Novartis, IBM Watson collab to optimize care for patients with advanced breast cancer
Drug Delivery Business News
Novartis
IBM Watson
advanced breast cancer
patients
breast cancer
Flag link:
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Marketwatch
Eli Lilly
advanced breast cancer
clinical trials
abemaciclib
Flag link:
Pfizer an Count on Ibrance for Upside and Massive Sales
Pfizer an Count on Ibrance for Upside and Massive Sales
Bidness, ETC
Pfizer
Ibrance
breast cancer
advanced breast cancer
Flag link:
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Yahoo
Eli Lilly
abemaciclib
advanced breast cancer
FDA
breakthrough therapies
Flag link:
Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer
Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer
Yahoo
Pfizer
breast cancer
grants
R&D
advanced breast cancer
Flag link:
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review
Yahoo
Pfizer
palbociclib
FDA
advanced breast cancer
Flag link: